Skip to content

Decreasing Pain, Improving Muscle Strength and Quality of Life For OA Knee Patients Using Hydrotherapy and Progressive Resistance Exercises

Effects of Hydrotherapy Versus Progressive Resistance Exercise in Patients With Primary Tibiofemoral Osteoarthritis of Knee in Decreasing Pain, Improving Muscle Strength and Quality of Life - Nil

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/04/066103
Enrollment
30
Registered
2024-04-23
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M171- Unilateral primary osteoarthritisof knee

Interventions

Intervention1: hydrotherapy: 40 minutes of treatment duration for alternate days for 6 weeks for each subects Control Intervention1: progressive resistance exercise: 40 minutes of treatment duration f

Sponsors

Kavya M
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Mild and moderate primary tibiofemoral osteoarthritis of knee according to Kellgren and Lawrence classification Male and female Unilateral primary tibiofemoral OA of knee Age group 45 to 55 years

Exclusion criteria

Exclusion criteria: Hydrophobia Lower limb joint replacement Recent trauma in lower limb Using any walking support and inability to walk Open wounds Skin infection Urinary or fecal incontinence Neurological disease Psychiatric disorder Epilepsy Knee deformities Spinal surgeries Limb shortening ACL injuries and reconstruction

Design outcomes

Primary

MeasureTime frame
Decreasing Pain Improving Muscle Strength Quality of LifeTimepoint: At baseline and after 6 weeks

Secondary

MeasureTime frame
nilTimepoint: nil

Countries

India

Contacts

Public ContactProf V S Seetharaman

Sri Ramakrishna Institute of Paramedical Sciences

seeraman_vs@yahoo.com9842744406

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026